MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has scheduled a live investor webcast for December 11, 2024, at 4:30 PM EST. The event will feature critical updates on the company’s progress and plans for 2025, with Dr. Maria Maccecchini, Founder, President, and CEO, leading the presentation.
The webcast will provide insight into several key areas, including the latest milestones in Annovis Bio’s efforts to combat neurodegenerative diseases. Key topics to be covered are:
- Clinical Progress: Updates on Phase 3 studies focused on treatments for Parkinson’s and Alzheimer’s diseases.
- Regulatory Milestones: Developments in the company’s interactions with the U.S. Food and Drug Administration (FDA) and plans for future submissions.
- Financial Overview: A look at the company’s financial health and funding strategies.
- Strategic Outlook: Goals for advancing therapies for neurodegenerative conditions in the upcoming year.
Register here. The webcast will also include a Q&A session, allowing participants to engage directly. Annovis Bio encourages registrants to submit their questions in advance via email at ir@annovisbio.com.
This webcast offers investors and stakeholders an opportunity to hear directly about Annovis Bio’s vision, strategy, and progress as it works toward solutions for some of the most challenging neurological conditions.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.